Vitamin D3 supplementation in COVID-19 patients with cardiovascular disease and gut dysbiosis | ||
| dc.conicet.organizacion | Universidad del Aconcagua. Facultad de Ciencias Médicas | |
| dc.conicet.organizacion | No especifíca | |
| dc.conicet.organizacion | Universidad del Aconcagua. Facultad de Ciencias Médicas | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo | |
| dc.conicet.organizacion | Universidad Maimónides | |
| dc.conicet.organizacion | Universidad Maimónides | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo | |
| dc.contributor.author | Sanz, R. L. | |
| dc.contributor.author | García, F. | |
| dc.contributor.author | Gutierrez, A. | |
| dc.contributor.author | García Menéndez, Sebastián Marcelo Manuel | |
| dc.contributor.author | Inserra, F. | |
| dc.contributor.author | Ferder, L. | |
| dc.contributor.author | Manucha, Walter Ariel Fernando | |
| dc.date.issued | 2024-06 | |
| dc.description.abstract | Background: The COVID-19 pandemic has highlighted the vulnerability of particular patient groups to SARS-CoV-2 infection, including those with cardiovascular diseases, hypertension, and intestinal dysbiosis. COVID-19 affects the gut, suggesting diet and vitamin D3 supplementation may affect disease progression. Aims: To evaluate levels of Ang II and Ang-(1-7), cytokine profile, and gut microbiota status in patients hospitalized for mild COVID-19 with a history of cardiovascular disease and treated with daily doses of vitamin D3. Methods: We recruited 50 adult patients and accessed pathophysiology study 22, randomized to daily oral doses of 10,000 IU vitamin D3 (n=11) or placebo (n=11). Plasma levels of Ang II and Ang-(1-7) were determined by radioimmunoassay, TMA and TMAO were measured by liquid chromatography and interleukins (ILs) 6, 8, 10 and TNF-α by ELISA. Results: The Ang-(1-7)/Ang II ratio, as an indirect measure of ACE2 enzymatic activity, increased in the vitamin D3 group (24±5 pg/mL vs 4.66±2 pg/mL, p<0.01). Also, in the vitamin D3-treated, there was a significant decline in inflammatory ILs and an increase in protective markers, such as a substantial reduction in TMAO (5±2 µmoles/dL vs 60±10 µmoles/dL, p<0.01). In addition, treated patients experienced less severity of infection, required less intensive care, had fewer days of hospitalization, and a reduced mortality rate. Additionally, improvements in markers of cardiovascular function were seen in the vitamin D3 group, including a tendency for reductions in blood pressure in hypertensive patients. Conclusions: Vitamin D3 supplementation in patients with COVID-19 and specific conditions is associated with a more favourable prognosis, suggesting therapeutic potential in patients with comorbidities such as cardiovascular disease and gut dysbiosis. | es |
| dc.description.fil | Fil: Sanz, R. L.. Universidad del Aconcagua. Facultad de Ciencias Médicas; Argentina | |
| dc.description.fil | Fil: García, F.. No especifíca; | |
| dc.description.fil | Fil: Gutierrez, A.. Universidad del Aconcagua. Facultad de Ciencias Médicas; Argentina | |
| dc.description.fil | Fil: García Menéndez, Sebastián Marcelo Manuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina | |
| dc.description.fil | Fil: Inserra, F.. Universidad Maimónides; Argentina | |
| dc.description.fil | Fil: Ferder, L.. Universidad Maimónides; Argentina | |
| dc.description.fil | Fil: Manucha, Walter Ariel Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Sanz, R. L.; García, F.; Gutierrez, A.; García Menéndez, Sebastián Marcelo Manuel; Inserra, F.; et al.; Vitamin D3 supplementation in COVID-19 patients with cardiovascular disease and gut dysbiosis; Elsevier; Hipertensión y Riesgo Vascular; 41; 3; 6-2024; 145-153 | es |
| dc.identifier.eissn | 2692-3106 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1889-1837 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/256499 | |
| dc.journal.number | 3 | es |
| dc.journal.pagination | 145-153 | es |
| dc.journal.pais | España | es |
| dc.journal.title | Hipertensión y Riesgo Vascular | es |
| dc.journal.volume | 41 | es |
| dc.language.iso | eng | es |
| dc.publisher | Elsevier | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.hipert.2024.04.002 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | COVID-19 | es |
| dc.subject | VITAMIN D3 | es |
| dc.subject | HYPERTENSION | es |
| dc.subject | GUT DYSBIOSIS | es |
| dc.subject.classification | Otras Medicina Clínica | es |
| dc.subject.classification | Medicina Clínica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Vitamin D3 supplementation in COVID-19 patients with cardiovascular disease and gut dysbiosis | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.59257462-d92d-4a84-bd74-548b31cf6e82_B.pdf
- Tamaño:
- 569.86 KB
- Formato:
- Adobe Portable Document Format